These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Methylation of the promoter region of the RASSF1A gene, a candidate tumor suppressor, in primary epithelial tumors]. Loginov VI; Maliukova AV; Seregin IuA; Khodyrev DS; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Kiselev LL; Zabarovskiĭ ER; Braga EA Mol Biol (Mosk); 2004; 38(4):654-67. PubMed ID: 15456137 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection. Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579 [TBL] [Abstract][Full Text] [Related]
4. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Cohen Y; Singer G; Lavie O; Dong SM; Beller U; Sidransky D Clin Cancer Res; 2003 Aug; 9(8):2981-4. PubMed ID: 12912945 [TBL] [Abstract][Full Text] [Related]
5. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma. Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383 [TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Tomizawa Y; Kohno T; Kondo H; Otsuka A; Nishioka M; Niki T; Yamada T; Maeshima A; Yoshimura K; Saito R; Minna JD; Yokota J Clin Cancer Res; 2002 Jul; 8(7):2362-8. PubMed ID: 12114441 [TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of the cpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Dammann R; Yang G; Pfeifer GP Cancer Res; 2001 Apr; 61(7):3105-9. PubMed ID: 11306494 [TBL] [Abstract][Full Text] [Related]
9. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof]. Cong DG; Wang SF Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310 [TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Hesson L; Bièche I; Krex D; Criniere E; Hoang-Xuan K; Maher ER; Latif F Oncogene; 2004 Mar; 23(13):2408-19. PubMed ID: 14743209 [TBL] [Abstract][Full Text] [Related]
11. Frequent hypermethylation of the RASSF1A gene in prostate cancer. Liu L; Yoon JH; Dammann R; Pfeifer GP Oncogene; 2002 Oct; 21(44):6835-40. PubMed ID: 12360410 [TBL] [Abstract][Full Text] [Related]
12. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Dammann R; Takahashi T; Pfeifer GP Oncogene; 2001 Jun; 20(27):3563-7. PubMed ID: 11429703 [TBL] [Abstract][Full Text] [Related]
13. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma]. Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529 [TBL] [Abstract][Full Text] [Related]
14. RASSF3 and NORE1: identification and cloning of two human homologues of the putative tumor suppressor gene RASSF1. Tommasi S; Dammann R; Jin SG; Zhang XF; Avruch J; Pfeifer GP Oncogene; 2002 Apr; 21(17):2713-20. PubMed ID: 11965544 [TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680 [TBL] [Abstract][Full Text] [Related]
16. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799 [TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of RASSF1a in uveal melanoma. Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440 [TBL] [Abstract][Full Text] [Related]
18. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma. Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406 [TBL] [Abstract][Full Text] [Related]
19. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556 [TBL] [Abstract][Full Text] [Related]
20. Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women. Li Y; Wei Q; Cao F; Cao X Oncol Rep; 2008 May; 19(5):1149-53. PubMed ID: 18425370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]